ESC Premium Access

Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction

Congress Presentation

About the speaker

Doctor Masato Kawasaki

Osaka General Medical Center, Osaka (Japan)
0 follower

8 more presentations in this session

Prediction of ventricular tachyarrhythmias occurrence by changes in physiological parameters derived from implantable-cardioverter defibrillators

Speaker: Doctor N. Chan (Hong Kong, HK)


An evaluation of the effect of the subcutaneous implantable defibrillator smartpass filter on inappropriate shock reduction.

Speaker: Doctor T. Brouwer (Amsterdam, NL)


The effectiveness of the wearable cardioverter defibrillator in a real world environment

Speaker: Doctor C. Abrahim (Springfield, US)


Sudden cardiac arrest in patients with cardiac implantable electronic devices

Speaker: Doctor A. Sharifzadehgan (Paris, FR)


Implantable cardioverter-defibrillator therapy in patients presenting with acute coronary syndromes - useful before 40 days?

Speaker: Doctor J. Ferreira (Coimbra, PT)


Access the full session

Poster Session 1 - Device treatment of ventricular arrhythmias and sudden cardiac death

Speakers: Doctor M. Kawasaki, Doctor N. Chan, Doctor T. Brouwer, Doctor C. Abrahim, Doctor A. Sharifzadehgan...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb